Atlas Trials

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

Clinical trial NCT02067793 · COMPLETED

Trial details

NCT number
NCT02067793
Sponsor
Naurex, Inc, an affiliate of Allergan plc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2014-03-01
Primary completion
2015-02-01
Enrollment
151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.